Radiopharmaceutical Adverse Events and Product Defects reporting

All serious adverse events should always be reported via the MHRA and CHM (Commission on Human Medicines) portals:
YELLOW CARDS:  for serious pharmaceutical adverse events; see
BLUE CARDS: for medical devices adverse incidents; see
BNMS professional-led database for non-critical adverse events and product defects,  can be found here: